Get started today

Addressing Kidney and Liver Problems 

Presented by Dr Philip Blair, MD

About this module:

In this presentation, Dr Philip Blair MD discusses kidney and liver disorders and how medicinal cannabis, in particular CBD may assist in treatment. He covers how the endocannabinoid system is dysregulated in these conditions, the pathomechanisms by which CBD may work and some of the evidence from the scientific literature that suggests CBD may be efficacious.  

This presentation is suitable for healthcare practitioners and assumes a knowledge of the endocannabinoid system and the pharmacodynamics of medicinal cannabis constituents including CBD. 
Learning Outcomes

At the end of this module, learners will be able to:

  • Describe key pathomechanisms involved (broadly) in kidney and liver disease.
  • Explain how the endocannabinoid system is involved in kidney and liver disease.
  • Explain how CBD is able to address various pathways associated with kidney disease.
  • Explain how CBD is able to address various pathways associated with liver disease.
  • Debate some of the research findings in relation to the use of CBD in treatment of liver disease 
MEET THE INSTRUCTOR

Dr Philip Blair, MD

Dr. Philip Blair, MD, (Colonel, US Army, retired) is a Family Physician and consultant in disease management in the Northwest USA. He graduated from West Point in 1972, attended the University of Miami School of Medicine, training as an Army Family Physician and serving as a combat physician in the first Gulf War. After medical assignments in three continents and 29 years in uniform, he retired from the Army and has been consulting on complex disease management since 2000.

Dr. Blair has been studying, treating, and lecturing about the human body’s natural endocannabinoid system (ECS) since 2014. His goal is to restore health and performance by enhancing the ECS using diet, exercise, appropriate medications and non-psychoactive therapies.

Featured links

Connect with us

Created with